In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the forecast (2010–19) period.
This in-depth Excel databook covers the metabolic and endocrinology pipeline by company and phase.
Edit my basket
© Datamonitor 2014. All rights reserved
Terms & Conditions